Mihos Christos G, Capoulade Romain, Yucel Evin, Picard Michael H, Santana Orlando
Cardiac Ultrasound Laboratory, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Cardiac Ultrasound Laboratory, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Ann Thorac Surg. 2017 Mar;103(3):991-1004. doi: 10.1016/j.athoracsur.2016.09.083. Epub 2017 Feb 4.
Prosthetic valve endocarditis (PVE) is associated with significant morbidity, and the optimal treatment strategy has not been clearly defined. A systematic review and meta-analysis of 32 studies comparing valve reoperation and medical therapy was performed; it included 2,636 patients, with a mean follow-up of 22 months. A valve reoperation was associated with a lower risk of 30-day mortality, greater survival at follow-up, and a similar rate of PVE recurrence. Prospective studies are warranted to confirm these findings and to clarify clinical decision-making regarding the timing and necessity of a valve reoperation, as opposed to treatment with medical therapy alone.
人工瓣膜心内膜炎(PVE)与严重的发病率相关,且最佳治疗策略尚未明确界定。对32项比较瓣膜再次手术和药物治疗的研究进行了系统评价和荟萃分析;纳入了2636例患者,平均随访22个月。瓣膜再次手术与30天死亡率较低、随访时生存率较高以及PVE复发率相似相关。有必要进行前瞻性研究以证实这些发现,并阐明关于瓣膜再次手术时机和必要性的临床决策,与单纯药物治疗相对。